X-linked agammaglobulinemia

17,646views

X-linked agammaglobulinemia

Joana

Joana

Mycobacterium tuberculosis (Tuberculosis)
Tuberculosis: Pathology review
Diabetes insipidus
Diabetes mellitus
Hypoglycemics: Insulin secretagogues
Thyroid cancer
Thyroid nodules and thyroid cancer: Clinical
Diabetes mellitus: Clinical
Hypertriglyceridemia
Anatomy of the thyroid and parathyroid glands
Insulins
Diabetes mellitus
Adrenal masses: Pathology review
Adrenal masses and tumors: Clinical
Adrenal insufficiency: Pathology review
Primary adrenal insufficiency
Congenital adrenal hyperplasia
Adrenal gland histology
Adrenal masses: Pathology review
Adrenal masses and tumors: Clinical
Esophageal cancer
Gastric cancer
GERD, peptic ulcers, gastritis, and stomach cancer: Pathology review
Peptic ulcers and stomach cancer: Clinical
Colorectal cancer
Colorectal cancer: Clinical
Metaplasia and dysplasia
Diabetic nephropathy
Benign liver tumors
Hepatocellular carcinoma
Peptic ulcer
Peptic ulcer
Helicobacter pylori
Cirrhosis
Inflammatory bowel disease: Pathology review
Inflammatory bowel disease: Clinical
Gallbladder carcinoma
Wilson disease
Pancreatic cancer
Carcinoid syndrome
Acromegaly
Viral hepatitis
Hyperthyroidism: Clinical
Alcohol-associated liver disease
Non-alcoholic fatty liver disease
Pituitary adenoma
Non-steroidal anti-inflammatory drugs
Diarrhea: Clinical
Metabolic acidosis
Metabolic alkalosis
Ulcerative colitis
Crohn disease
Respiratory acidosis
Nephrotic syndromes: Pathology review
Goodpasture syndrome
Nephritic syndromes: Pathology review
Respiratory alkalosis
Cholestatic liver disease
Laxatives and cathartics
Polycystic ovary syndrome
MEN syndromes: Clinical
Autoimmune polyglandular syndrome type 1 (NORD)
Type I and type II errors
Gastroesophageal reflux disease (GERD)
Celiac disease
Polycystic kidney disease
Chronic kidney disease
Acute kidney injury: Clinical
IgA nephropathy (NORD)
Focal segmental glomerulosclerosis (NORD)
Minimal change disease
Chronic kidney disease: Clinical
Cytomegalovirus infection after transplant (NORD)
Hyperkalemia: Clinical
Atherosclerosis and arteriosclerosis: Pathology review
Portal hypertension
Cirrhosis: Clinical
Hypercholesterolemia: Clinical
Gallbladder histology
Chronic cholecystitis
Gout
Gout and pseudogout: Pathology review
Lesch-Nyhan syndrome
Macrocytic anemia: Pathology review
Alpha-thalassemia
Beta-thalassemia
Anemia: Clinical
Sickle cell disease (NORD)
Sickle cell disease: Clinical
Aplastic anemia
Von Willebrand disease
Acute leukemia
Lung cancer: Clinical
Lung cancer
Breast cancer: Clinical
Breast cancer
Monoclonal antibodies
Atrioventricular block
Heart blocks: Pathology review
Abnormal heart sounds
Heart failure
Pulmonary embolism
Pulmonary edema
Pulmonary valve disease
Cell-mediated immunity of CD4 cells
Cell-mediated immunity of natural killer and CD8 cells
Innate immune system
Introduction to the immune system
Complement system
T-cell development
B-cell development
MHC class I and MHC class II molecules
T-cell activation
B-cell activation, differentiation, and contraction
Antibody classes
Somatic hypermutation and affinity maturation
VDJ rearrangement
Contracting the immune response and peripheral tolerance
B- and T-cell memory
Vaccinations
Type I hypersensitivity
Food allergy
Anaphylaxis
Asthma
Type II hypersensitivity
Type III hypersensitivity
Type IV hypersensitivity
Graft-versus-host disease
Immunodeficiencies: T-cell and B-cell disorders: Pathology review
Immunodeficiencies: Combined T-cell and B-cell disorders: Pathology review
ELISA (Enzyme-linked immunosorbent assay)
Gel electrophoresis and genetic testing
Fluorescence in situ hybridization
Precipitation reactions
Isolated primary immunoglobulin M deficiency
Selective immunoglobulin A deficiency
Blood groups and transfusions
Systemic lupus erythematosus
Systemic lupus erythematosus (SLE): Pathology review
Systemic lupus erythematosus (SLE): Clinical
Chronic granulomatous disease
Complement deficiency
Immunodeficiencies: Phagocyte and complement dysfunction: Pathology review
DiGeorge syndrome
X-linked agammaglobulinemia
Hyper IgM syndrome
Leukocyte adhesion deficiency
Immunodeficiencies: Clinical
HIV (AIDS)
Cell-cell junctions
Hashimoto thyroiditis
Wiskott-Aldrich syndrome
Food allergies and EpiPens: Information for patients and families (The Primary School)
Vaccinations: Clinical
Blood products and transfusion: Clinical
Hypersensitivity skin reactions: Clinical
Shock: Clinical
Rheumatic heart disease
Immune thrombocytopenia
Rheumatoid arthritis
Rheumatoid arthritis: Clinical
Multiple sclerosis

Transcript

Watch video only

With X-linked agammaglobulinemia, or XLA for short, gamma globulin is another name for immunoglobulin, which is another name for antibodies, a- means without, and -emia refers to the blood.

So this is a disease where there aren’t any antibodies in the blood, and X-linked means that it’s caused by a gene mutation on the X chromosome.

Now, normally, immunoglobulins are secreted into the blood by plasma cells, which are fully matured or differentiated B cells, a type of immune cell.

Way before that ever happens, though, those B cells start out in the bone marrow as pluripotent stem cells, pluripotent meaning that they can develop into a number of different types of cells.

But to become a B cell, first that pluripotent stem cell differentiates into a lymphoid precursor cell, then a pro-B cell, then a pre-B cell, then an immature B cell which migrates from the bone marrow to the spleen, where it becomes a mature or naive B cell, which after being exposed to the right antigen, moves into the blood or lymph and becomes an antibody-secreting plasma cell.

In XLA, this maturation process stops at the pre-B cell stage.

Why does it do that? Well, by the immature B cell stage, it has a B cell receptor, which is a membrane-bound antibody, specifically an immunoglobulin M or IgM.

But in the Pre- and Pro-B cell stages, this B cell receptor’s still being assembled, once it’s finished, it’s made up of heavy chain and light chain protein subunits, and the heavy chains are put together first.

Since it hasn’t been fully assembled yet, this IgM’s known as a pre-B cell receptor.

Now, an enzyme called bruton’s tyrosine kinase is super important for both the development and normal functioning of the B cell receptor.

With XLA, though, there’s a mutation in the BTK gene which makes the BTK enzyme ineffective.

And because of this ineffective BTK enzyme, the B cell maturation process gets stopped at this Pre-B cell stage, meaning no B cells leave the bone marrow, so ultimately people with XLA completely lack or have far fewer circulating B cells, and since B cells turn into plasma cells, which produce immunoglobulins or antibodies, they also lack circulating antibodies of all classes.

In the bone marrow, they might have normal or decreased levels of pre-B cells, with IgM heavy chains found in their cytoplasm.

Key Takeaways

X-linked agammaglobulinemia (XLA) is an x-linked genetic disorder of the immune system caused by mutations in the BTK (Bruton's tyrosine kinase) gene. XLA primarily affects males, as they only have one X chromosome, while females have two and are typically carriers of the mutated gene. Individuals with XLA have a deficiency in B cells. This results in an inability to mount an effective immune response against bacterial infections, leading to recurrent and often severe infections, especially of the respiratory tract and ears. The symptoms of XLA typically appear in early childhood, and affected individuals may experience recurrent bacterial infections, chronic diarrhea, and failure to thrive.

Sources

  1. "Harrison's Principles of Internal Medicine, Twentieth Edition (Vol.1 & Vol.2)" McGraw-Hill Education / Medical (2018)
  2. "CURRENT Medical Diagnosis and Treatment 2020" McGraw-Hill Education / Medical (2019)
  3. "Yen & Jaffe's Reproductive Endocrinology" Saunders W.B. (2018)
  4. "Bates' Guide to Physical Examination and History Taking" LWW (2016)
  5. "Robbins Basic Pathology" Elsevier (2017)
  6. "X-Linked Agammaglobulinemia Patients Are Not Infected with Epstein-Barr Virus: Implications for the Biology of the Virus" Journal of Virology (1999)
  7. "Autoimmunity in Primary Immunodeficiency Disorders: An Updated Review on Pathogenic and Clinical Implications" Journal of Clinical Medicine (2021)
  8. "Peripheral B Cell Deficiency and Predisposition to Viral Infections: The Paradigm of Immune Deficiencies" Frontiers in Immunology (2021)
  9. "B-cell biology and development" Journal of Allergy and Clinical Immunology (2013)